1. Sebanc P.: Stabilnost kanabidiola in ostalih kanabinoidov v rastlinskih oljih in maslih.
Magistrsko delo. Ljubljana, 2019.
2. Tavčar-Benković E., Štrukelj B., Razinger-Mihovec B., Kržan B., Peterlin-Mišič M., Perković-Benedik L., Knez M., Sollner-Dolenc M., Gosenca-Matjaž M., Tomašič T., Kočevar-Glavač N., Jakopin Ž.: Uporaba kanabinoidov: strokovno izpopolnjevanje s področja farmacije, Univerza v Ljubljani, Fakulteta za farmacijo, Ljubljana, 2019: 7-19 in 47-56.
3. Bonini S. A., Premoli M., Tambaro S., Kumar A., Maccarinelli G., Memo M., Mastinu A.:
Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. Journal of Ethnopharmacology 2018; 227: 300-315.
4. Francke N. M., Schneider F., Baumann K., Bunjes H.: Formulation of Cannabidiol in Colloidal Lipid Carriers, Molecules 2021, 26.
5. Bragança V. A. N., França T. G., de Jesus A. C. S. P. S., Palheta I. C., Melo F. P. A., Neves P. A. P. F. G., Lima A. B., Borges R. S.: Impact of conformational and solubility properties on psycho-activity of cannabidiol, Chemical Data Collections 2020, 26.
6. Zou S., Kumar U.: Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. International Journal of Molecular Sciences 2018; 19:
833.
7. Lu H. C., Mackie K.: Review of the Endocannabinoid System. Biological Psychiatry 2020;
6: 607-615.
8. Huestis M. A., Solimini R., Pichini S., Pacifici R., Carlier J., Busardò F. P.: Cannabidiol Adverse Effects and Toxicity. Current Neuropharmacology 2019; 17: 974–989.
9. EMA, SmPC za zdravilo Epidyolex. Datum dostopa: 20. 9. 2021.
https://www.ema.europa.eu/en/documents/product-information/epidyolex-epar-product-information_sl.pdf
10. Blessing E. M., Steenkamp M. M., Manzanares J., Marmar C. R.: Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics 2015; 12: 825–836.
11. Davies C., Bhattacharyya S.: Cannabidiol as a potential treatment for psychosis. Ther Adv Psychopharmacol 2019; 9: 1-16.
12.Electronic medicines compendium (emc), SmPC za zdravilo Sativex. Datum dostopa: 27.
9. 2021.
https://www.medicines.org.uk/emc/product/602/smpc
45
13. Millar S. A., Stone N. L., Yates A. S., O'Sullivan S. E.: A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. Front Pharmacol 2018;9.
14. Izgelov D., Davidson E., Barasch D., Regev A., Domb A. J., Hoffman A.: Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers. Eur. J. of Pharmaceutics and Biopharmaceutics 2020; 154: 108-115.
15. Ramírez M., Amate L., Gil A.: Absorption and distribution of dietary fatty acids from different sources. Early Hum Dev. 2001; 65: 95-101.
16. Ohlsson A., Lindgren J. E., Andersson S., Agurell S., Gillespie H., Hollister L. E.: Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed. Environ. Mass Spectrom. 1986; 13: 77-83.
17. Žižek P.: Razvoj analiznih metod visoke zmogljivosti za določanje topnosti in porazdelitvenega koeficienta snovi. Magistrsko delo. Ljubljana, 2020.
18. Baka E., Comer J. E. A., Takács-Novák K.: Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J. Pharm.
Biomed. Anal. 2008; 46: 335-341.
19. Herrera-Pool E., Ramos-Díaz A. L., Lizardi-Jiménez M. A., Pech-Cohuo S., Ayora-Talavera T., Cuevas-Bernardino J. C., García-Cruz U., Pacheco N.: Effect of solvent polarity on the Ultrasound Assisted extraction and antioxidant activity of phenolic compounds from habanero pepper leaves (Capsicum chinense) and its identification by UPLC-PDA-ESI-MS/MS. Ultrasonics Sonochemistry 2021; 76.
20. Zhuang B., Ramanauskaite G., Koa Z. Y., Wang Z.: Like dissolves like: A first-principles theory for predicting liquid miscibility and mixture dielectric constant. Sci Adv 2021; 7.
21. Moldoveanu S. C., David V.: Essentials in Modern HPLC Separations, Chapter 7 -Mobile Phases and Their Properties. Elsevier Inc, Amsterdam, 2013: 363-447.
22. ICH M9 smernice. Datum dostopa: 21. 9. 2021
https://www.ema.europa.eu/en/documents/scientific-guideline/ich-m9-biopharmaceutics-classification-system-based-biowaivers-step-5_en.pdf
23. Vlad R. A., Antonoaea P., Todoran N., Muntean D. L., Rédai E. M., Silași O. A., Tătaru A., Bîrsan M., Imre S., Ciurba A.: Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets. Saudi Pharmaceutical Journal; 29: 1029-1042.
24. Formularium Slovenicum FS 5.1 – peta izdaja. 2021.
25. Veseli A., Žakelj S., Kristl A.: A review of methods for solubility determination in biopharmaceutical drug characterization. Drug Development and Industrial Pharmacy 2019;
45: 1717-1724.
46
26. Tong W. Q.: Practical Aspects of Solubility Determination in Pharmaceutical Preformulation. Springer, New York, 2007: 137-149.
27. Bergström C. A. S., Norinder U., Luthman K., Artursson P.: Experimental and computational screening models for prediction of aqueous drug solubility. Pharmaceutical Research 2002; 19: 182-188.
28. Sou T., Bergström C. A. S.: Automated assays for thermodynamic (equilibrium) solubility determination. Drug Discovery Today: Technologies 2018; 27: 11-19.
29. Kerns E. H., Di L., Carter G. T.: In vitro solubility assays in drug discovery. Current Drug Metabolism 2008; 9: 879-885.
30. Könczöl A., Dargó G.: Brief overview of solubility methods: Recent trends in equilibrium solubility measurement and predictive models. Drug Discovery Today: Technologies 2018; 27:
3-10.
31. Hewitt M., Cronin M. T. D., Enoch S. J., Madden J. C., Roberts D. W., Dearden J. C.: In silico prediction of aqueous solubility: the solubility challenge. J. of Chemical Information and Modeling 2009; 49: 2572-2587.
32. Bergström C. A. S., Larsson P.: Computational prediction of drug solubility in water-based systems: Qualitative and quantitative approaches used in the current drug discovery and development setting. International Journal of Pharmaceutics 2018; 540: 185-193.
33. Templar Smith B.: Remington Education: Physical Pharmacy, Pharmaceutical Press, London, 2015: 31-50.
34. Di L., Kerns E. H.: Drug-Like Properties, Academic Press, Cambridge, 2016: 15-28.
35. Kosović E., Sýkora D., Kuchar M.: Stability Study of Cannabidiol in the Form of Solid Powder and Sunflower Oil Solution. Pharmaceutics 2021; 13: 412.
36. Fraguas-Sánchez A. I., Fernández-Carballido A., Martin-Sabroso C., Torres-Suárez A. I.:
Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies. Journal of Chromatography B 2020; 1150.
37. Pavlovic R., Nenna G., Calvi L., Panseri S., Borgonovo G., Giupponi L., Cannazza G., Giorgi A.: Quality Traits of "Cannabidiol Oils": Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations. Molecules 2018;
23: 1230.
38. Millar S. A., Maguire R. F., Yates A. S., O’Sullivan S. E.: Towards Better Delivery of Cannabidiol (CBD). Pharmaceuticals 2020; 13: 219.
47
39. Hrastnik J.: Vpliv načina izolacije in dekarboksilacije na kemijsko stabilnost ekstrakta industrijske konoplje. Magistrsko delo. Ljubljana, 2020.
40. Turpeinen A., Merimaa P.: Functional Foods (Second edition), 16-Functional fats and spreads. Woodhead Publishing, Sawston, 2011: 383-400.
41. Myrie S. B., Jones P. J. H.: Functional Foods (Second edition), 10-Functional foods and obesity. Woodhead Publishing, Sawston, 2011: 234-260.
42. Callaway J. C., Pate D. W.: Gourmet and Health-Promoting Specialty Oils, 5-Hempseed Oil. Elsevier Inc, Amsterdam, 2009: 185-213.
43. Pérez-Rodrigo C., Aranceta J.: Encyclopedia of Food and Health, Olive Oil: Its Role in the Diet. Elsevier, Amsterdam, 2016: 158-166.
44. Parker J., Schellenberger A. N., Roe A. L., Oketch-Rabah H., Calderón A.I.: Therapeutic Perspectives on Chia Seed and Its Oil: A Review. Planta Medica 2018; 84: 606-612.
45. Lv P., Zhang D., Guo M., Liu J., Chen X., Guo R., Xu Y., Zhang Q., Liu Y., Guo H., Yang M.: Structural analysis and cytotoxicity of host-guest inclusion complexes of cannabidiol with three native cyclodextrins. Journal of Drug Delivery Science and Technology 2019; 51: 337-344.
46.Lozano-Sánchez J., Borrás-Linares I., Sass-Kiss A., Segura-Carretero A.: Modern Techniques for Food Authentication (Second Edition), Chapter 13-Chromatographic Technique: High-Performance Liquid Chromatography (HPLC). Elsevier Inc, Amsterdam, 2018: 459-526.
47. Yaneva Z., Georgieva N.: Nanoscale Fabrication, Optimization, Scale-Up and Biological Aspects of Pharmaceutical Nanotechnology, Chapter 5 - Physicochemical and morphological characterization of pharmaceutical nanocarriers and mathematical modeling of drug encapsulation/release mass transfer processes. Elsevier Inc, Amsterdam, 2018: 173-218.
48. Poole C.F.: Encyclopedia of Separation Science, Chromatography. Elsevier Science, Amsterdam, 2000, 40-64.
49. Brighenti V., Protti M., Anceschi L., Zanardi C., Mercolini L., Pellati F.: Emerging challenges in the extraction, analysis and bioanalysis of cannabidiol and related compounds.
Journal of Pharmaceutical and Biomedical Analysis 2021; 192.
50. Štefančič M.: Validacija HPLC metode za selektivno določanje kanabinoidov. Diplomsko delo. Ljubljana, 2020.
51. EMA, Etanol kot pomožna snov. Datum dostopa: 3. 10. 2021.
https://www.ema.europa.eu/en/documents/scientific-guideline/information-package-leaflet-regarding-ethanol-used-excipient-medicinal-products-human-use_en.pdf
48
52. Peri C.: The Extra-Virgin Olive Oil Handbook, John Wiley & Sons, New York, 2014:
349-60
53. Segura-Campos M. R., Ciau-Solís N., Rosado-Rubio G., Chel-Guerrero L., Betancur-Ancona D.: Physicochemical characterization of chia (Salvia hispanica) seed oil from Yucatán, México. Agricultural Sciences 2014; 5.
54. Anwar F., Latif S., Ashraf M.: Analytical Characterization of Hemp (Cannabis sativa) Seed Oil from Different Agro-ecological Zones of Pakistan. AOCS 2006; 83: 323-329.
55. Internetni vir, datum dostopa 11. 10. 2021
https://www.aciscience.org/docs/Physical_properties_of_glycerine_and_its_solutions.pdf 56. Ahumada E. A., Delgado D. R., Martínez F.: Solution thermodynamics of acetaminophen in some PEG 400 + water mixtures. Fluid Phase Equilibria 2012; 332: 120-127.
57. Internetni vir, datum dostopa: 6. 10. 2021 https://www.caymanchem.com/pdfs/90081.pdf 58. Internetni vir, datum dostopa: 6. 10. 2021
https://hempture.ie/wp-content/uploads/2020/03/uHemp_CBD_MSDS.pdf 59. Internetni vir, datum dostopa: 6. 10. 2021
https://www.tocris.com/products/minus-cannabidiol_1570#product-details
60. Casiraghi A., Musazzi U. M., Centin G., Franzè S., Minghetti P.: Topical Administration of Cannabidiol: Influence of Vehicle-Related Aspects on Skin Permeation Process.
Pharmaceuticals 2020; 13: 337.
61. Stinchcomb A. L., Valiveti S., Hammell D. C., Ramsey D. R.: Human skin permeation of Δ8-tetrahydrocannabinol, cannabidiol and cannabinol. Journal of Pharmacy and Pharmacology 2004; 56: 291–297.
62. Shigetomi Y., Ishimura Y., Yamamoto Y.: Trends in global dependency on the Indonesian palm oil and resultant environmental impacts. Scientific Reports 2020; 10.
49